A detailed history of Solitude Financial Services transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Solitude Financial Services holds 10,310 shares of BMY stock, worth $591,072. This represents 0.23% of its overall portfolio holdings.

Number of Shares
10,310
Previous 8,801 17.15%
Holding current value
$591,072
Previous $365,000 46.03%
% of portfolio
0.23%
Previous 0.17%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$39.66 - $51.75 $59,846 - $78,090
1,509 Added 17.15%
10,310 $533,000
Q2 2024

Jul 19, 2024

BUY
$40.25 - $52.99 $112,740 - $148,424
2,801 Added 46.68%
8,801 $365,000
Q1 2024

Apr 22, 2024

BUY
$47.98 - $54.4 $287,880 - $326,400
6,000 New
6,000 $325,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Solitude Financial Services Portfolio

Follow Solitude Financial Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Solitude Financial Services, based on Form 13F filings with the SEC.

News

Stay updated on Solitude Financial Services with notifications on news.